Literature DB >> 23524663

Metabolism studies of unformulated internally [3H]-labeled short interfering RNAs in mice.

Jesper Christensen1, Karine Litherland, Thomas Faller, Esther van de Kerkhof, François Natt, Jürg Hunziker, Joel Krauser, Piet Swart.   

Abstract

Absorption, distribution, metabolism, and excretion properties of two unformulated model short interfering RNA (siRNAs) were determined using a single internal [(3)H]-radiolabeling procedure, in which the full-length oligonucleotides were radiolabeled by Br/(3)H -exchange. Tissue distribution, excretion, and mass balance of radioactivity were investigated in male CD-1 mice after a single intravenous administration of the [(3)H]siRNAs, at a target dose level of 5 mg/kg. Quantitative whole-body autoradiography and liquid scintillation counting techniques were used to determine tissue distribution. Radiochromatogram profiles were determined in plasma, tissue extracts, and urine. Metabolites were separated by liquid chromatography and identified by radiodetection and high-resolution accurate mass spectrometry. In general, there was little difference in the distribution of total radiolabeled components after administration of the two unformulated [(3)H]siRNAs. The radioactivity was rapidly and widely distributed throughout the body and remained detectable in all tissues investigated at later time points (24 and 48 hours for [(3)H]MRP4 (multidrug resistance protein isoform 4) and [(3)H]SSB (Sjögren Syndrome antigen B) siRNA, respectively). After an initial rapid decrease, concentrations of total radiolabeled components in dried blood decreased at a much slower rate. A nearly complete mass balance was obtained for the [(3)H]SSB siRNA, and renal excretion was the main route of elimination (38%). The metabolism of the two model siRNAs was rapid and extensive. Five minutes after administration, no parent compound could be detected in plasma. Instead, radiolabeled nucleosides resulting from nuclease hydrolysis were observed. In the metabolism profiles obtained from various tissues, only radiolabeled nucleosides were found, suggesting that siRNAs are rapidly metabolized and that the distribution pattern of total radiolabeled components can be ascribed to small molecular weight metabolites.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23524663     DOI: 10.1124/dmd.112.050666

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  16 in total

Review 1.  Lipid nanoparticles for gene delivery.

Authors:  Yi Zhao; Leaf Huang
Journal:  Adv Genet       Date:  2014       Impact factor: 1.944

Review 2.  Pharmacokinetics and biodistribution of recently-developed siRNA nanomedicines.

Authors:  Jinho Park; Joonyoung Park; Yihua Pei; Jun Xu; Yoon Yeo
Journal:  Adv Drug Deliv Rev       Date:  2015-12-10       Impact factor: 15.470

3.  PK-modifying anchors significantly alter clearance kinetics, tissue distribution, and efficacy of therapeutics siRNAs.

Authors:  Bruno M D C Godinho; Emily G Knox; Samuel Hildebrand; James W Gilbert; Dimas Echeverria; Zachary Kennedy; Reka A Haraszti; Chantal M Ferguson; Andrew H Coles; Annabelle Biscans; Jillian Caiazzi; Julia F Alterman; Matthew R Hassler; Anastasia Khvorova
Journal:  Mol Ther Nucleic Acids       Date:  2022-06-13       Impact factor: 10.183

4.  Pharmacokinetic Profiling of Conjugated Therapeutic Oligonucleotides: A High-Throughput Method Based Upon Serial Blood Microsampling Coupled to Peptide Nucleic Acid Hybridization Assay.

Authors:  Bruno M D C Godinho; James W Gilbert; Reka A Haraszti; Andrew H Coles; Annabelle Biscans; Loic Roux; Mehran Nikan; Dimas Echeverria; Matthew Hassler; Anastasia Khvorova
Journal:  Nucleic Acid Ther       Date:  2017-10-12       Impact factor: 5.486

5.  Pharmacodynamic and Pharmacokinetic Properties of Full Phosphorothioate Small Interfering RNAs for Gene Silencing In Vivo.

Authors:  Christian Berk; Gianluca Civenni; Yuluan Wang; Christian Steuer; Carlo V Catapano; Jonathan Hall
Journal:  Nucleic Acid Ther       Date:  2020-04-20       Impact factor: 5.486

Review 6.  RNAi Efficiency, Systemic Properties, and Novel Delivery Methods for Pest Insect Control: What We Know So Far.

Authors:  Mallikarjuna R Joga; Moises J Zotti; Guy Smagghe; Olivier Christiaens
Journal:  Front Physiol       Date:  2016-11-17       Impact factor: 4.566

Review 7.  Lipid Nanovectors to Deliver RNA Oligonucleotides in Cancer.

Authors:  Virginia Campani; Giuseppina Salzano; Sara Lusa; Giuseppe De Rosa
Journal:  Nanomaterials (Basel)       Date:  2016-07-09       Impact factor: 5.076

8.  Dendrimer-coated carbon nanotubes deliver dsRNA and increase the efficacy of gene knockdown in the red flour beetle Tribolium castaneum.

Authors:  Catriona H Edwards; Craig R Christie; Andrea Masotti; Antonella Celluzzi; Andrea Caporali; Ewan M Campbell
Journal:  Sci Rep       Date:  2020-07-24       Impact factor: 4.379

9.  ADME studies of [5-(3)H]-2'-O-methyluridine nucleoside in mice: a building block in siRNA therapeutics.

Authors:  Frederic Lozac'h; Jesper Christensen; Thomas Faller; Esther van de Kerkhof; Joel Krauser; Maxime Garnier; Karine Litherland; Alexandre Catoire; Francois Natt; Jurg Hunziker; Piet Swart
Journal:  Pharmacol Res Perspect       Date:  2016-02-01

10.  Knocking Down TMPRSS2-ERG Fusion Oncogene by siRNA Could be an Alternative Treatment to Flutamide.

Authors:  Giorgia Urbinati; Isabelle de Waziers; Mateja Slamiç; Tobias Foussignière; Hafiz M Ali; Didier Desmaële; Patrick Couvreur; Liliane Massaad-Massade
Journal:  Mol Ther Nucleic Acids       Date:  2016-03-29       Impact factor: 10.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.